JG
MRVI icon

Jain Global’s Maravai LifeSciences MRVI Stock Holding History

Jain Global’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,216
Closed -$36.5K – 1499
2025
Q4 		$36.5K Buy
+11,216
New +$37.8K ﹤0.01% 1175
2025
Q2 		– Sell
-112,139
Closed -$248K – 1473
2025
Q1 		$248K Buy
+112,139
New +$443K ﹤0.01% 750

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jain Global's MRVI Position: Q1 2026 in Review

Jain Global sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 11,216 shares — an estimated $36.5K sold.

Jain Global first reported a position in MRVI in Q1 2025 and held it in 2 quarters. The position peaked at $248K in Q1 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Jain Global reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Jain Global sold 11,216 Maravai LifeSciences shares in Q1 2026, an estimated $36.5K.
  • Jain Global first reported a position in Maravai LifeSciences in Q1 2025 and held it in 2 quarters.
  • Jain Global's Maravai LifeSciences position peaked at $248K in Q1 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.